Correlation Between Alvotech and Citius Oncology,
Can any of the company-specific risk be diversified away by investing in both Alvotech and Citius Oncology, at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Alvotech and Citius Oncology, into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Alvotech and Citius Oncology,, you can compare the effects of market volatilities on Alvotech and Citius Oncology, and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Alvotech with a short position of Citius Oncology,. Check out your portfolio center. Please also check ongoing floating volatility patterns of Alvotech and Citius Oncology,.
Diversification Opportunities for Alvotech and Citius Oncology,
-0.75 | Correlation Coefficient |
Pay attention - limited upside
The 3 months correlation between Alvotech and Citius is -0.75. Overlapping area represents the amount of risk that can be diversified away by holding Alvotech and Citius Oncology, in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Citius Oncology, and Alvotech is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Alvotech are associated (or correlated) with Citius Oncology,. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Citius Oncology, has no effect on the direction of Alvotech i.e., Alvotech and Citius Oncology, go up and down completely randomly.
Pair Corralation between Alvotech and Citius Oncology,
Given the investment horizon of 90 days Alvotech is expected to generate 0.24 times more return on investment than Citius Oncology,. However, Alvotech is 4.11 times less risky than Citius Oncology,. It trades about 0.04 of its potential returns per unit of risk. Citius Oncology, is currently generating about -0.2 per unit of risk. If you would invest 830.00 in Alvotech on August 30, 2024 and sell it today you would earn a total of 338.00 from holding Alvotech or generate 40.72% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Weak |
| Accuracy | 15.56% |
| Values | Daily Returns |
Alvotech vs. Citius Oncology,
Performance |
| Timeline |
| Alvotech |
| Citius Oncology, |
Alvotech and Citius Oncology, Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Alvotech and Citius Oncology,
The main advantage of trading using opposite Alvotech and Citius Oncology, positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Alvotech position performs unexpectedly, Citius Oncology, can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Citius Oncology, will offset losses from the drop in Citius Oncology,'s long position.| Alvotech vs. Intracellular Th | Alvotech vs. Catalent | Alvotech vs. Amphastar P | Alvotech vs. Assertio Therapeutics |
| Citius Oncology, vs. Phibro Animal Health | Citius Oncology, vs. Procaps Group SA | Citius Oncology, vs. Amphastar P | Citius Oncology, vs. Alkermes Plc |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Content Syndication module to quickly integrate customizable finance content to your own investment portal.
Other Complementary Tools
| Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
| Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
| Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
| Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk |